High-dose dexamethasone treatment for COVID-19 severe acute respiratory distress syndrome: a retrospective study

Low-dose dexamethasone reduces mortality in patients with coronavirus disease 2019 (COVID-19)-related acute respiratory distress syndrome (ARDS). We retrospectively analyzed the efficacy of high-dose dexamethasone in patients with COVID-19-related ARDS and evaluated factors affecting the composite o...

Descripción completa

Detalles Bibliográficos
Autores principales: Vecchié, Alessandra, Batticciotto, Alberto, Tangianu, Flavio, Bonaventura, Aldo, Pennella, Benedetta, Abenante, Alessia, Corso, Rossana, Grazioli, Stefano, Mumoli, Nicola, Para, Ombretta, Maresca, Andrea Maria, Dalla Gasperina, Daniela, Dentali, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Im - Original
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286167/
https://www.ncbi.nlm.nih.gov/pubmed/34275096
http://dx.doi.org/10.1007/s11739-021-02800-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286167/
https://www.ncbi.nlm.nih.gov/pubmed/34275096
http://dx.doi.org/10.1007/s11739-021-02800-1

Ejemplares similares